Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$69.25BHealthcare Market cap, Sector
Bio-Techne
TECH$9.07BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 TECH
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsTECH
84B
D47
87A
B81
92A
F42
66C
F16
75B
F42
91A
F37
95A
F36
Side-by-side metrics
| Metric | JSLL.NS | TECH |
|---|---|---|
| Market cap | Winner: $69.25B | $9.07B |
| P/E (TTM) | Winner: 33.3x | 61.6x |
| EV/EBIT | Winner: 24.1x | 67.1x |
| ROIC (TTM) | Winner: 39.15% | 4.75% |
| Gross margin | Winner: 88.58% | 64.96% |
| Net margin | Winner: 27.68% | 9.05% |
| Revenue CAGR 5y | Winner: 57.81% | 6.98% |
| EPS CAGR 5y | Winner: 86.67% | -15.23% |
| Debt / Equity | 0.3x | 0.1x Winner |
| Dividend yield | - | 0.74% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- EPS CAGR 5y86.67%vs -15.23%+118%
- Revenue CAGR 5y57.81%vs 6.98%+88%
- ROIC (TTM)39.15%vs 4.75%+88%
- Market cap$69.25Bvs $9.07B+87%
TECH leads on
- Debt / Equity0.1xvs 0.3x+49%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.